FR2744731B1 - Nouveaux variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique - Google Patents

Nouveaux variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique

Info

Publication number
FR2744731B1
FR2744731B1 FR9601603A FR9601603A FR2744731B1 FR 2744731 B1 FR2744731 B1 FR 2744731B1 FR 9601603 A FR9601603 A FR 9601603A FR 9601603 A FR9601603 A FR 9601603A FR 2744731 B1 FR2744731 B1 FR 2744731B1
Authority
FR
France
Prior art keywords
nucleic acid
acid sequences
gene therapy
thymidine kinase
corresponding nucleic
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9601603A
Other languages
English (en)
Other versions
FR2744731A1 (fr
Inventor
Francis Blanche
Beatrice Cameron
Michel Couder
Joel Crouzet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharma SA
Original Assignee
Rhone Poulenc Rorer SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR9601603A priority Critical patent/FR2744731B1/fr
Application filed by Rhone Poulenc Rorer SA filed Critical Rhone Poulenc Rorer SA
Priority to KR1019980705846A priority patent/KR19990082124A/ko
Priority to PCT/FR1997/000193 priority patent/WO1997029196A1/fr
Priority to BR9707483A priority patent/BR9707483A/pt
Priority to CZ19982479A priority patent/CZ294497B6/cs
Priority to EP97902417A priority patent/EP0879288A1/fr
Priority to IL12559797A priority patent/IL125597A0/xx
Priority to JP9528208A priority patent/JP2000505288A/ja
Priority to HU9902571A priority patent/HUP9902571A3/hu
Priority to AU16068/97A priority patent/AU720936B2/en
Priority to CA 2245508 priority patent/CA2245508A1/fr
Priority to US09/125,099 priority patent/US6207150B1/en
Priority to SK1079-98A priority patent/SK107998A3/sk
Priority to ZA9701086A priority patent/ZA971086B/xx
Publication of FR2744731A1 publication Critical patent/FR2744731A1/fr
Application granted granted Critical
Publication of FR2744731B1 publication Critical patent/FR2744731B1/fr
Priority to NO983449A priority patent/NO983449L/no
Priority to US09/734,357 priority patent/US20020102247A1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1205—Phosphotransferases with an alcohol group as acceptor (2.7.1), e.g. protein kinases
    • C12N9/1211—Thymidine kinase (2.7.1.21)
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR9601603A 1996-02-09 1996-02-09 Nouveaux variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique Expired - Fee Related FR2744731B1 (fr)

Priority Applications (16)

Application Number Priority Date Filing Date Title
FR9601603A FR2744731B1 (fr) 1996-02-09 1996-02-09 Nouveaux variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique
CA 2245508 CA2245508A1 (fr) 1996-02-09 1997-01-31 Variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique
BR9707483A BR9707483A (pt) 1996-02-09 1997-01-31 Sequência de ácidos nucléicos que codificam para uma timidina quinase variante de uma timidina quinase selvagem variante de uma timidina quinase do vírus do herpes simplex de tipo 1 veículo de expressão vetor e composição farmacêutica
CZ19982479A CZ294497B6 (cs) 1996-02-09 1997-01-31 Sekvence nukleové kyseliny kódující nové varianty enzymu thymidinkinázy a farmaceutické kompozice obsahující takovou nukleovou kyselinu nebo variantu thymidinkinázy
EP97902417A EP0879288A1 (fr) 1996-02-09 1997-01-31 Variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique
IL12559797A IL125597A0 (en) 1996-02-09 1997-01-31 Variants of thymidine kinase related nucleic acids sequences and their use in genic therapy
JP9528208A JP2000505288A (ja) 1996-02-09 1997-01-31 チミジンキナーゼ変異体、対応する核酸配列および遺伝子治療におけるそれらの用途
HU9902571A HUP9902571A3 (en) 1996-02-09 1997-01-31 Variants of thymidine kinase, related nucleic acids sequences and their use in genic therapy
KR1019980705846A KR19990082124A (ko) 1996-02-09 1997-01-31 티미딘 키나제의 변이체, 관련 핵산서열 및 유전자 요법에있어서 이들의 용도
PCT/FR1997/000193 WO1997029196A1 (fr) 1996-02-09 1997-01-31 Variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique
US09/125,099 US6207150B1 (en) 1996-02-09 1997-01-31 Variants of thymidine kinase, nucleic acids encoding them, and methods of using them
SK1079-98A SK107998A3 (en) 1996-02-09 1997-01-31 Variants of thymidine kinase, related nucleic acids sequences and their use in genic therapy
AU16068/97A AU720936B2 (en) 1996-02-09 1997-01-31 Thymidine kinase variants, corresponding nucleic acid sequences and their use in gene therapy
ZA9701086A ZA971086B (en) 1996-02-09 1997-02-10 New thymidine kinase variants, corresponding nucleic acid sequences and their use in gene therapy.
NO983449A NO983449L (no) 1996-02-09 1998-07-27 Varianter av thymidinkinase, tilsvarende nukleinsyresekvenser og deres anvendelse ved genterapi
US09/734,357 US20020102247A1 (en) 1996-02-09 2000-12-12 Variants of thymidine kinase, related nucleic acids sequences and their use in genic therapy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9601603A FR2744731B1 (fr) 1996-02-09 1996-02-09 Nouveaux variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique

Publications (2)

Publication Number Publication Date
FR2744731A1 FR2744731A1 (fr) 1997-08-14
FR2744731B1 true FR2744731B1 (fr) 1998-05-22

Family

ID=9489024

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9601603A Expired - Fee Related FR2744731B1 (fr) 1996-02-09 1996-02-09 Nouveaux variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique

Country Status (2)

Country Link
FR (1) FR2744731B1 (fr)
ZA (1) ZA971086B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0008966D0 (en) 2000-04-13 2000-05-31 Imp College Innovations Ltd Vectors for gene therapy
GB0413702D0 (en) 2004-06-18 2004-07-21 Molmed Spa Thymidine kinase

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69524740T2 (de) * 1994-05-02 2002-08-14 University Of Washington, Seattle Thymidin-kinase-mutanten

Also Published As

Publication number Publication date
FR2744731A1 (fr) 1997-08-14
ZA971086B (en) 1997-08-25

Similar Documents

Publication Publication Date Title
FR2731014B1 (fr) Molecules d'adn, preparation et utilisation en therapie genique
NO983449D0 (no) Varianter av thymidinkinase, tilsvarende nukleinsyresekvenser og deres anvendelse ved genterapi
AP2000001812A0 (en) Novel modified nucleic acid sequences and methods for increasing mrna levels and protein expression in cell systems
EP0948513A4 (fr) Produit de recombinaison pour l'administration d'acides nucleiques antisens et ses procedes d'utilisation
IT9083334A0 (it) Procedimento per l'estrazione e la purificazione di dna genomico umano
HUP9801639A3 (en) Genetic sequences and proteins related to alzheimer's disease, and uses therefor
GB9622500D0 (en) Therapeutic gene
EP0960114A4 (fr) Polymorphismes et nouveaux genes dans la region du gene humain de l'hemochromatose
FR2775295B1 (fr) Fragment d'adn specifique de streptococcus agalactiae et molecules d'acides nucleiques apparentees
IT1226210B (it) Procedimento per l'estrazione e la purificazione di dna
FR2744731B1 (fr) Nouveaux variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique
IL88095A0 (en) Dna sequences,proteins and gene preparations
NO981322D0 (no) Farmasöytiske preparater for bruk ved nukleinsyretransfeksjon, og deres anvendelse
FR2751988B1 (fr) Nouveaux variants de la thymidine kinase, sequences d'acides nucleiques correspondantes et leur utilisation en therapie genique
IT9020072A0 (it) Cellule umane per l'elevata espressione di geni inseriti in dna ricombinanti episomiali,loro preparazione e loro impiego
FR2768748B1 (fr) Recodage de sequences d'adn permettant leur expression dans les levures et levures transformees obtenues
AU5671299A (en) Dna encoding human monocyte-macrophage apolipoprotein b receptor gene and protein
ITMI941560A0 (it) Oligonucleotidi antisenso complementari all'rna messaggero del recettore umano della urochinasi
FR2722295B1 (fr) Methode d'analyse d'adn dite sscp et gel d'electro-phorene
MA25182A1 (fr) Histones de trypanosomatides, genes et derives de genes les codant, construction d'adn vecteur, organisme hote, tests et vaccins correspondants et leur utilisation
FR2757524B1 (fr) Polypeptides de la famille bhlh, sequences d'acides nucleiques correspondantes
FR2748753B1 (fr) Nouveaux vecteurs adenoviraux pour la therapie genique
FR2756564B1 (fr) Derives d'acide quinoleine-8-carboxylique, leur preparation et leur application en therapeutique
FR2751970B1 (fr) Derives d'acide 6,7,8,9-tetrahydro-5h-imidazo[1,2-a]azepine- 3-acetique, leur preparation et leur application en therapeutique
FR2817868B1 (fr) Nouvelle proteine issue du gene de l'hormone de melanoconcentration "melanin-concentrating hormone" (mch), acides nucleiques correspondants et leur application a la preparation de medicaments

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse

Effective date: 20061031